High level expression of the drug efflux pump ABCB1 leading to active efflux from blast cells of standard-of-care chemotherapy drugs such as daunorubicin and cytarabine is one of the strongest predictors for induction failure in acute myeloid leukemia (AML) [1]. Here, ABCB1 is linked to acute myeloid leukemia.